Skip to main navigation Skip to search Skip to main content

Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD

  • SPIRIT-IOIBD study group
  • CHU Nantes
  • CHU de Nancy

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD'. Together they form a unique fingerprint.
Sort by

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology